CELIAC DISEASE FOUNDATION
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$4,294,353
Contributions
56%
Program Services
39%
Investments
4%
Other
2%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Expenses in 2024
$4,336,074
Salaries & Benefits
53%
Other
26%
Grants
13%
Depreciation
4%
Offices, Occupancy & IT
3%
Fees to Service Providers
1%
Benefits to Members
0%
Advertising & Promotion
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$1,927,788
$2,407,287
+25%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$2,154,436
$1,662,305
-23%
Membership Dues
$0
$0
-
Investments
$90,475
$151,617
+68%
Other
$30,744
$73,144
+138%
Total Revenues
$4,203,443
$4,294,353
+2%
Expenses
2023
2024
Change
Grants
$249,000
$572,500
+130%
Benefits to Members
$0
$0
-
Salaries & Benefits
$1,561,157
$2,280,100
+46%
Fees to Service Providers
$109,339
$52,538
-52%
Advertising & Promotion
$0
$0
-
Offices, Occupancy & IT
$126,237
$115,877
-8%
Interest
$0
$0
-
Depreciation
$25,236
$175,604
+596%
Other
$904,266
$1,139,455
+26%
Total Expenses
$2,975,235
$4,336,074
+46%
Net income
2023
2024
Change
Net income
+$1,228,208
-$41,721
-103%
Functional Expenses
Summary
2023
2024
Change
Program
$2,429,552
$3,267,192
+34%
Admin
$197,274
$431,431
+119%
Fundraising
$348,409
$637,451
+83%
Total Expenses
$2,975,235
$4,336,074
+46%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)